Timber Creek Capital Management LLC Has $5.15 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Timber Creek Capital Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 10.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 10,033 shares of the healthcare conglomerate’s stock after purchasing an additional 990 shares during the quarter. UnitedHealth Group makes up approximately 1.7% of Timber Creek Capital Management LLC’s investment portfolio, making the stock its 25th biggest position. Timber Creek Capital Management LLC’s holdings in UnitedHealth Group were worth $5,153,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $4,478,185,000. Arrowstreet Capital Limited Partnership raised its position in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of UnitedHealth Group by 60.4% during the 1st quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock valued at $2,580,442,000 after acquiring an additional 1,886,128 shares during the last quarter. Capital Research Global Investors raised its position in shares of UnitedHealth Group by 8.3% during the 1st quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after acquiring an additional 1,482,338 shares during the last quarter. Finally, Invesco Ltd. increased its position in shares of UnitedHealth Group by 28.3% in the 1st quarter. Invesco Ltd. now owns 6,018,008 shares of the healthcare conglomerate’s stock valued at $3,069,002,000 after buying an additional 1,328,237 shares in the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. In the last ninety days, insiders sold 139,051 shares of company stock worth $74,450,958. Insiders own 0.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research report on Thursday, September 8th. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Argus upped their price objective on shares of UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a research report on Monday, July 25th. Finally, UBS Group upped their target price on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $586.40.

UnitedHealth Group Trading Up 1.1 %

UnitedHealth Group stock opened at $517.46 on Friday. The firm has a 50-day moving average of $530.11 and a 200-day moving average of $512.45. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The company has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same period last year, the business posted $4.70 EPS. UnitedHealth Group’s revenue was up 12.6% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were paid a $1.65 dividend. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.